Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE
Equities
TEVA
IL0006290147
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,370.00 ILa | -0.84% |
|
-2.48% | -7.14% |
| Capitalization | 36.4B 0 30.91B 28.54B 26.91B 49.91B 3,387B 50.78B 334B 131B 1,629B 137B 134B 5,794B | P/E ratio 2026 * |
24.2x | P/E ratio 2027 * | 17.6x |
|---|---|---|---|---|---|
| Enterprise value | 47.38B 0 40.24B 37.15B 35.02B 64.97B 4,409B 66.1B 435B 171B 2,121B 178B 174B 7,542B | EV / Sales 2026 * |
2.87x | EV / Sales 2027 * | 2.55x |
| Free-Float |
90.76% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Teva Pharmaceutical Industries Limited
| 1 day | -0.84% | ||
| 1 week | -2.48% | ||
| Current month | +1.42% | ||
| 1 month | -0.22% | ||
| 3 months | -6.10% | ||
| 6 months | +46.13% | ||
| Current year | -7.14% |
| 1 week | 9,294 |  | 9,669 |
| 1 month | 8,860 | | 9,669 |
| Current year | 8,860 | | 11,350 |
| 1 year | 4,865 | | 11,350 |
| 3 years | 2,637 | | 11,350 |
| 5 years | 2,383 | | 11,350 |
| 10 years | 2,175 | | 21,770 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 2022-12-31 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 2019-12-21 |
Matthew Shields
COO | Chief Operating Officer | - | 2024-06-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 2008-12-31 |
Sol Barer
CHM | Chairman | 78 | 2017-02-05 |
Rosemary Crane
BRD | Director/Board Member | 66 | 2015-08-31 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +2.26% | 0.03% | 33,076 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.84% | -2.48% | - | - | 36.4B | |
| -0.11% | -5.36% | +23.01% | +141.24% | 809B | |
| -1.73% | -2.81% | +52.39% | +41.43% | 565B | |
| +0.27% | -1.61% | +21.73% | +29.33% | 370B | |
| -0.33% | -0.35% | +24.06% | +13.94% | 320B | |
| +0.03% | -2.44% | +46.76% | +25.66% | 312B | |
| -2.07% | -5.89% | +51.01% | +0.13% | 285B | |
| +0.10% | -3.48% | +29.67% | +33.39% | 286B | |
| +0.34% | -1.75% | +23.62% | +39.76% | 189B | |
| -0.23% | +6.69% | -34.17% | -55.86% | 180B | |
| Average | +0.22% | -1.64% | +26.45% | +29.89% | 368.27B | |
| Weighted average by Cap. | +0.66% | -2.44% | +30.13% | +50.68% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.5B 0 14.01B 12.94B 12.2B 22.63B 1,535B 23.02B 152B 59.43B 739B 61.9B 60.61B 2,626B | 17.14B 0 14.56B 13.44B 12.67B 23.51B 1,595B 23.91B 158B 61.74B 767B 64.31B 62.96B 2,728B |
| Net income | 1.63B 0 1.38B 1.27B 1.2B 2.23B 151B 2.27B 14.93B 5.85B 72.74B 6.1B 5.97B 259B | 2.16B 0 1.83B 1.69B 1.6B 2.96B 201B 3.01B 19.84B 7.77B 96.62B 8.1B 7.93B 344B |
| Net Debt | 10.98B 0 9.33B 8.61B 8.12B 15.06B 1,022B 15.32B 101B 39.56B 492B 41.2B 40.34B 1,748B | 7.37B 0 6.26B 5.78B 5.45B 10.11B 686B 10.29B 67.77B 26.56B 330B 27.67B 27.09B 1,174B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-04-17 | 9,370.00 ILa | -0.84% | 807,606 |
| 26-04-16 | 9,449.00 ILa | +0.14% | 1,200,914 |
| 26-04-15 | 9,436.00 ILa | -1.19% | 790,898 |
| 26-04-14 | 9,550.00 ILa | +2.19% | 1,212,891 |
| 26-04-13 | 9,345.00 ILa | -2.74% | 1,063,580 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TEVA Stock
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions
